|
ZNF362 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.932200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.199200E-01 |
| Normal-vs-Stage2 |
8.296200E-02 |
| Normal-vs-Stage3 |
8.430400E-01 |
| Normal-vs-Stage4 |
3.933800E-01 |
| Stage1-vs-Stage2 |
2.735800E-01 |
| Stage1-vs-Stage3 |
1.100210E-01 |
| Stage1-vs-Stage4 |
2.766500E-02 |
| Stage2-vs-Stage3 |
3.930400E-02 |
| Stage2-vs-Stage4 |
1.685610E-02 |
| Stage3-vs-Stage4 |
5.053800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.582200E-01 |
| Normal-vs-AfricanAmerican |
1.523960E-01 |
| Normal-vs-Asian |
2.110600E-01 |
| Caucasian-vs-AfricanAmerican |
2.391800E-01 |
| Caucasian-vs-Asian |
3.393400E-01 |
| AfricanAmerican-vs-Asian |
6.675200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.406300E-02 |
| Normal-vs-Female |
8.041000E-01 |
| Male-vs-Female |
2.425900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.417800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.320600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.186800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.367800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.738600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.661800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.037620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.648600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.140210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.022640E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.248500E-04 |
| Classical-VS-Follicular |
4.551200E-01 |
| Classical-VS-Other |
8.739800E-01 |
| Classical-VS-Normal |
3.052400E-01 |
| Tall-VS-Follicular |
6.241600E-04 |
| Tall-VS-Other |
2.009200E-01 |
| Tall-VS-Normal |
4.750300E-02 |
| Follicular-VS-Other |
9.337400E-01 |
| Follicular-VS-Normal |
1.492360E-01 |
| Other-VS-Normal |
5.344600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.908200E-02 |
| Normal-vs-N1 |
4.715000E-01 |
| N0-vs-N1 |
1.519560E-02 |
|
|
